Cargando…

A Non-VH1-69 Heterosubtypic Neutralizing Human Monoclonal Antibody Protects Mice against H1N1 and H5N1 Viruses

Influenza viruses are among the most important human pathogens and are responsible for annual epidemics and sporadic, potentially devastating pandemics. The humoral immune response plays an important role in the defense against these viruses, providing protection mainly by producing antibodies direc...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Marco, Donata, Clementi, Nicola, Mancini, Nicasio, Solforosi, Laura, Moreno, Guisella J., Sun, Xiangjie, Tumpey, Terrence M., Gubareva, Larisa V., Mishin, Vasiliy, Clementi, Massimo, Burioni, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319592/ https://www.ncbi.nlm.nih.gov/pubmed/22496802 http://dx.doi.org/10.1371/journal.pone.0034415

Ejemplares similares

A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes
por: Clementi, Nicola, et al.
Publicado: (2011)

Phage Display-based Strategies for Cloning and Optimization of Monoclonal Antibodies Directed against Human Pathogens
por: Clementi, Nicola, et al.
Publicado: (2012)

A closer look at prion strains: Characterization and important implications
por: Solforosi, Laura, et al.
Publicado: (2013)

Novel Pandemic Influenza A(H1N1) Viruses Are Potently Inhibited by DAS181, a Sialidase Fusion Protein
por: Triana-Baltzer, Gallen B., et al.
Publicado: (2009)

HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A Concurrent Pathogenetic Role
por: Sautto, Giuseppe, et al.
Publicado: (2012)

Neutralization Interfering Antibodies: A “Novel” Example of Humoral Immune Dysfunction Facilitating Viral Escape?
por: Nicasio, Mancini, et al.
Publicado: (2012)

Acquired heterosubtypic antibodies in human immunity for avian H5N1 influenza
por: Lynch, Garry W, et al.
Publicado: (2009)

Boosting Heterosubtypic Neutralization Antibodies in Recipients of 2009 Pandemic H1N1 Influenza Vaccine
por: Qiu, Chao, et al.
Publicado: (2012)

Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2)
por: te Beest, Dennis E., et al.
Publicado: (2017)

H1 Hemagglutinin Priming Provides Long-Lasting Heterosubtypic Immunity against H5N1 Challenge in the Mouse Model
por: Carreño, Juan Manuel, et al.
Publicado: (2020)

Mammalian pathogenicity and transmissibility of low pathogenic avian influenza H7N1 and H7N3 viruses isolated from North America in 2018
por: Belser, Jessica A., et al.
Publicado: (2020)

Changes in heterosubtypic antibody responses during the first year of the 2009 A(H1N1) influenza pandemic
por: Freidl, Gudrun S., et al.
Publicado: (2016)

Anti-HIV-1 Response Elicited in Rabbits by Anti-Idiotype Monoclonal Antibodies Mimicking the CD4-Binding Site
por: Burioni, Roberto, et al.
Publicado: (2008)

Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM(+) Memory B Cells
por: Throsby, Mark, et al.
Publicado: (2008)

Use of Highly Pathogenic Avian Influenza A(H5N1) Gain-Of-Function Studies for Molecular-Based Surveillance and Pandemic Preparedness
por: Davis, C. Todd, et al.
Publicado: (2014)

Heterosubtype Neutralizing Responses to Influenza A (H5N1) Viruses Are Mediated by Antibodies to Virus Haemagglutinin
por: Garcia, Jean-Michel, et al.
Publicado: (2009)

Cluster of Oseltamivir-Resistant and Hemagglutinin Antigenically Drifted Influenza A(H1N1)pdm09 Viruses, Texas, USA, January 2020
por: Mohan, Teena, et al.
Publicado: (2021)

Influenza B-cells Protective Epitope Characterization: A Passkey for the Rational Design of New Broad-Range Anti-Influenza Vaccines
por: Clementi, Nicola, et al.
Publicado: (2012)

Transcriptomic Characterization of the Novel Avian-Origin Influenza A (H7N9) Virus: Specific Host Response and Responses Intermediate between Avian (H5N1 and H7N7) and Human (H3N2) Viruses and Implications for Treatment Options
por: Josset, Laurence, et al.
Publicado: (2014)

Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses
por: Price, Graeme E., et al.
Publicado: (2010)

An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus
por: Zhao, Guangyu, et al.
Publicado: (2010)

Molecular Signatures of Hepatitis C Virus (HCV)-Induced Type II Mixed Cryoglobulinemia (MCII)
por: Sautto, Giuseppe, et al.
Publicado: (2012)

JC Polyomavirus (JCV) and Monoclonal Antibodies: Friends or Potential Foes?
por: Diotti, Roberta Antonia, et al.
Publicado: (2013)

Prophylactic and Therapeutic Efficacy of Avian Antibodies Against Influenza Virus H5N1 and H1N1 in Mice
por: Nguyen, Huan H., et al.
Publicado: (2010)

Heterosubtypic anti-avian H5N1 influenza antibodies in intravenous immunoglobulins from globally separate populations protect against H5N1 infection in cell culture
por: Sullivan, John S, et al.
Publicado: (2009)

A Biologically-validated HCV E1E2 Heterodimer Structural Model
por: Castelli, Matteo, et al.
Publicado: (2017)

Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Isolated from Poultry, Vietnam, 2009–2011
por: Nguyen, Ha T., et al.
Publicado: (2013)

Detection and Characterization of Clade 1 Reassortant H5N1 Viruses Isolated from Human Cases in Vietnam during 2013
por: Thor, Sharmi W., et al.
Publicado: (2015)

Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells
por: Legastelois, Isabelle, et al.
Publicado: (2007)

Poly-γ-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccine
por: Yang, Jihyun, et al.
Publicado: (2017)

H1N1pdm Influenza Infection in Hospitalized Cancer Patients: Clinical Evolution and Viral Analysis
por: Souza, Thiago Moreno L., et al.
Publicado: (2010)

An Investigational Antiviral Drug, DAS181, Effectively Inhibits Replication of Zoonotic Influenza A Virus Subtype H7N9 and Protects Mice From Lethality
por: Marjuki, Henju, et al.
Publicado: (2014)

Possible Future Monoclonal Antibody (mAb)-Based Therapy against Arbovirus Infections
por: Sautto, Giuseppe, et al.
Publicado: (2013)

A Single Mutation in the PB1-F2 of H5N1 (HK/97) and 1918 Influenza A Viruses Contributes to Increased Virulence
por: Conenello, Gina M, et al.
Publicado: (2007)

Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011–2018
por: Jorquera, Patricia A., et al.
Publicado: (2019)

Heterosubtypic Antibody Response Elicited with Seasonal Influenza Vaccine Correlates Partial Protection against Highly Pathogenic H5N1 Virus
por: Ding, Heng, et al.
Publicado: (2011)

Vaccination against Human Influenza A/H3N2 Virus Prevents the Induction of Heterosubtypic Immunity against Lethal Infection with Avian Influenza A/H5N1 Virus
por: Bodewes, Rogier, et al.
Publicado: (2009)

Asparagine Substitution at PB2 Residue 701 Enhances the Replication, Pathogenicity, and Transmission of the 2009 Pandemic H1N1 Influenza A Virus
por: Zhou, Bin, et al.
Publicado: (2013)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Mexico
por: Ramirez-Gonzalez, José Ernesto, et al.
Publicado: (2011)

Pathogenesis and Transmissibility of North American Highly Pathogenic Avian Influenza A(H5N1) Virus in Ferrets
por: Pulit-Penaloza, Joanna A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6lftpgeh6nag1236h296ma93lr